Streetbeat News

Earnings

DUOL

Duolingo shares surged following the announcement of their Q4 financial results, which exceeded expectations. The company also provided optimistic future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:26 pm

CWAN

Clearwater Analytics Holdings reported its Q1 2024 revenue forecast to be $100.5 million, which is below the estimated $101.812 million.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:26 pm

RVNC

Revance Therapeutics (NASDAQ:RVNC) reported Q4 earnings with losses of $(0.62) per share, surpassing the $(0.72) estimate, and sales of $69.80M, exceeding the $62.63M estimate. This represents a significant improvement over the previous year's performance.

Portfolio Pulse from Happy Mohamed

February 28, 2024 | 9:26 pm

AMPH

Amphastar Pharma (NASDAQ:AMPH) reported Q4 earnings of $0.88 per share, missing the consensus estimate of $0.91 by 3.3%. However, their quarterly sales of $178.10M exceeded the estimate of $175.67M by 1.39%, marking a 31.91% increase from the previous year.

Portfolio Pulse from Happy Mohamed

February 28, 2024 | 9:25 pm

HPQ

HP Inc's shares dropped following the announcement of Q1 sales results that fell short of expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:25 pm

PNTG

Pennant Gr (NASDAQ:PNTG) reported Q4 earnings with an EPS of $0.22, matching the estimate and showing a revenue increase of $21.29 million from the previous year. Despite matching EPS estimates, past performance indicates a potential positive reaction in share price following earnings announcements.

Portfolio Pulse from Benzinga Insights

February 28, 2024 | 9:25 pm

SHLS

Shoals Technologies projects its Q1 2024 revenue to be between $90M and $100M, which is significantly lower than the estimated $133.730M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:24 pm

PNTG

Pennant Gr (PNTG) reported Q4 2023 earnings of $0.22 per share, meeting analyst estimates, with sales of $145.95M, exceeding the $136.43M estimate by 6.98%. This represents a 17.08% increase over the previous year's sales of $124.67M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:24 pm

SRPT

Sarepta Therapeutics' stock is trading higher following the announcement of their Q4 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:24 pm

SHLS

Shoals Technologies projects its FY24 revenue to be between $480M-$520M, which is significantly lower than the estimated $622.703M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:24 pm